Offer - Urjas Oil for just ₹ 1 X
Pregaba D 75/30 Capsule DR (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Pregaba D 75/30 Capsule DR (10) safe for pregnant women?
Pregaba D Capsule can have harmful effects in pregnant women. If you experience any discomfort after using Pregaba D Capsule, then discontinue the use and take your doctor's advice.
Is the use of Pregaba D 75/30 Capsule DR (10) safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Pregaba D Capsule. It should only be taken after medical advice.
What is the effect of Pregaba D 75/30 Capsule DR (10) on the Kidneys?
Pregaba D Capsule rarely harms the kidneys.
What is the effect of Pregaba D 75/30 Capsule DR (10) on the Liver?
Using Pregaba D Capsule does not have any harmful effects on the liver.
What is the effect of Pregaba D 75/30 Capsule DR (10) on the Heart?
Using Pregaba D Capsule does not have any harmful effects on the heart.
Pregaba D 75/30 Capsule DR (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Pregaba D 75/30 Capsule DR (10) unless your doctor advises you to do so -
Is this Pregaba D 75/30 Capsule DR (10) habit forming or addictive?
No, you will not get addicted to Pregaba D 75/30 Capsule DR (10).
Interaction between Food and Pregaba D 75/30 Capsule DR (10)
It is safe to take Pregaba D 75/30 Capsule DR (10) with food.
Interaction between Alcohol and Pregaba D 75/30 Capsule DR (10)
Consult your doctor before consuming alcohol while taking Pregaba D 75/30 Capsule DR (10) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 474-475
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 462
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cymbalta (duloxetine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420